Skip to content

Takahide Koda

Director at Immunis.

Raised on Immunis filings

$12M

of $12M offered across 1 Form D filing

Form D filings
1
Teammates
3
Last filing
Jun 15, 2026

Company

Immunis

Biotech · Irvine, CA

Stem cell secretome biologic for age-related muscle loss

Investors
12

Immunis filings

  • Option to acquireFiled Jun 15, 2026Form D
    $12M/ $12M

Works with